BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 12243834)

  • 21. Variation in sensitizing effect of caffeine in human tumour cell lines after gamma-irradiation.
    Valenzuela MT; Mateos S; Ruiz de Almodóvar JM; McMillan TJ
    Radiother Oncol; 2000 Mar; 54(3):261-71. PubMed ID: 10738085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylxanthine sensitization of human colon cancer cells to 186Re-labeled monoclonal antibody.
    Kinuya S; Yokoyama K; Kudo M; Kasahara Y; Kobayashi K; Motoishi S; Onoma K; Bunko H; Michigishi T; Tonami N
    J Nucl Med; 2001 Apr; 42(4):596-600. PubMed ID: 11337548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abrogation of G(2)/M-phase block enhances the cytotoxicity of daunorubicin, melphalan and cisplatin in TP53 mutant human tumor cells.
    Binder AB; Serafin AM; Bohm LJ
    Radiat Res; 2000 Dec; 154(6):640-9. PubMed ID: 11096420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells.
    Dwarakanath BS; Adhikari JS; Jain V
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Abrogation of radiation-induced G2 arrest and radiosensitization by 7-hydroxystaurosporine (UCN-01) in human nasopharyngeal carcinoma cell line].
    Hui ZG; Li YX; Yang WZ; Wu JX; Yu ZH
    Ai Zheng; 2003 Jan; 22(1):6-10. PubMed ID: 12561427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemosensitivity of prostatic tumour cell lines under conditions of G2 block abrogation.
    Serafin AM; Binder AB; Böhm L
    Urol Res; 2001 Jun; 29(3):221-7. PubMed ID: 11482451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro studies of PDR brachytherapy].
    Fritz P; Frank C; Weber KJ
    Strahlenther Onkol; 1998 Jul; 174(7):365-74. PubMed ID: 9689958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estramustine sensitizes human glioblastoma cells to irradiation.
    Yoshida D; Piepmeier J; Weinstein M
    Cancer Res; 1994 Mar; 54(6):1415-7. PubMed ID: 8137240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol).
    Liebmann J; Cook JA; Fisher J; Teague D; Mitchell JB
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):559-64. PubMed ID: 7911794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bioreductive agent RH1 and gamma-irradiation both cause G2/M cell cycle phase arrest and polyploidy in a p53-mutated human breast cancer cell line.
    Kim JY; Kim CH; Stratford IJ; Patterson AV; Hendry JH
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):376-85. PubMed ID: 14751506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosensitization in multifraction schedules. II. Greater sensitization by 2-nitroimidazoles than by oxygen.
    Taylor YC; Brown JM
    Radiat Res; 1987 Oct; 112(1):134-45. PubMed ID: 3659294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA damage in cultured skin microvascular endothelial cells exposed to gamma rays and treated by the combination pentoxifylline and alpha-tocopherol.
    Laurent C; Voisin P; Pouget JP
    Int J Radiat Biol; 2006 May; 82(5):309-21. PubMed ID: 16782648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective radiosensitization of human cervical cancer cells and normal cells by artemisinin through the abrogation of radiation-induced G2 block.
    Gong XM; Zhang Q; Torossian A; Cao JP; Fu S
    Int J Gynecol Cancer; 2012 Jun; 22(5):718-24. PubMed ID: 22552829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures.
    Mitchell CR; Joiner MC
    Int J Radiat Biol; 2002 Nov; 78(11):981-90. PubMed ID: 12456285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT.
    Shibamoto Y; Ito M; Sugie C; Ogino H; Hara M
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1484-90. PubMed ID: 15275736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vitro study of a paclitaxel-radiotherapy combination on a human epidermoid tumor cell line].
    Pradier O; Laurent D; Schmidberger H; Rave-Fränk M; Rubisch K; Krebeck M; Weiss E; Hess CF
    Cancer Radiother; 1999; 3(1):51-6. PubMed ID: 10083863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines.
    Stromberg JS; Lee YJ; Armour EP; Martinez AA; Corry PM
    Cancer; 1995 May; 75(9):2262-8. PubMed ID: 7712434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro radiosensitization by pentoxifylline does not depend on p53 status.
    Akudugu JM; Serafin AM; Böhm LJ
    Int J Radiat Biol; 2013 Jun; 89(6):462-70. PubMed ID: 23363223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay.
    Powell SN; DeFrank JS; Connell P; Eogan M; Preffer F; Dombkowski D; Tang W; Friend S
    Cancer Res; 1995 Apr; 55(8):1643-8. PubMed ID: 7712468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of homologous recombination repair with Pentoxifylline targets G2 cells generated by radiotherapy and induces major enhancements of the toxicity of cisplatin and melphalan given after irradiation.
    Bohm L
    Radiat Oncol; 2006 May; 1():12. PubMed ID: 16722614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.